VAXCELL-BIO

The current price of 323990 is 16790 KRW — it has increased by 2.25% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange VAXCELL-BIO stocks are traded under the ticker 323990.

323990 stock is 3.17% volatile and has beta coefficient of 1.94. Check out the list of the most volatile stocks — is VAXCELL-BIO there?

Yes, you can track VAXCELL-BIO financials in yearly and quarterly reports right on TradingView.

323990 stock has fallen by 6.20% compared to the previous week, the month change is a 20.61% fall, over the last year VAXCELL-BIO has showed a 68.32% decrease.

323990 net income for the last quarter is ‪−2.72 B‬ KRW, while the quarter before that showed ‪−2.81 B‬ KRW of net income which accounts for 3.24% change. Track more VAXCELL-BIO financial stats to get the full picture.

No, 323990 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 323990 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VAXCELL-BIO stock right from TradingView charts — choose your broker and connect to your account.

323990 reached its all-time high on Jan 7, 2021 with the price of 234270 KRW, and its all-time low was 7990 KRW and was reached on Oct 20, 2020.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has 57.00 employees. See our rating of the largest employees — is VAXCELL-BIO on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VAXCELL-BIO technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VAXCELL-BIO stock shows the strong sell signal. See more of VAXCELL-BIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VAXCELL-BIO EBITDA is ‪−10.85 B‬ KRW, and current EBITDA margin is ‪−79.19 K‬%. See more stats in VAXCELL-BIO financial statements.